merck glp-1 signs weight loss pill licensing deal with Hansoh Pharma Merck Enters into Exclusive Global

Lack of insurance coverage remains one of the greatest barriers to people accessing GLP-1 drugs

These compounds work by blocking damaging pathways, clearing senescent cells, and activating RXFP1 receptors to limit scarring

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

I kept waiting for it not to work

At YNC, we deliver glutathione through IV therapy, IM injections, or nebulized therapy, depending on your health goals

Retatrutide is an investigational peptide currently being studied for its interaction with three key metabolic receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors